Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Veterinary Research|September 15, 2020
Immune responses upon experimental Erysipelothrix rhusiopathiae infection of naïve and vaccinated chickensEva Wattrang, Helena Eriksson, Tomas Jinnerot, et al.
Vaccine|February 22, 2024
Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSPJordan Plieskatt, Peter Bang, Grith Krøyer Wood, et al.
Human Vaccines & Immunotherapeutics|April 10, 2025
Magnitude and durability of ProC6C-AlOH/Matrix-M<sup>tm</sup> vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trialMohammad Naghizadeh, Kazutoyo Miura, Ebenezer Addo Ofori, et al.
Communications Biology|July 18, 2023
Human blood neutrophils generate ROS through FcγR-signaling to mediate protection against febrile P. falciparum malariaEbenezer Addo Ofori, Asier Garcia-Senosiain, Mohammad Naghizadeh, et al.
AMB Express|April 26, 2021
Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cellsHassan Noorbazargan, Sobhan Amintehrani, Aghigh Dolatabadi, et al.
Frontiers in Immunology|November 18, 2024
ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adultsJordan Plieskatt, Ebenezer Addo Ofori, Mohammad Naghizadeh, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
The Journal of Clinical Investigation|January 30, 2024
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adultsAlfred B Tiono, Jordan L Plieskatt, Alphonse Ouedraogo, et al.
Pageof 2